Open AccessCirculating asymmetric dimethylarginine and the risk of preeclampsia: a meta-analysis based on 1338 participants
Author(s) -
Jing Yuan,
Xinguo Wang,
Yudou Xie,
Yuzhi Wang,
Lei Dong,
Hong Li,
Tongyu Zhu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.16543
Subject(s) - preeclampsia , asymmetric dimethylarginine , medicine , meta analysis , incidence (geometry) , confidence interval , subgroup analysis , gastroenterology , endocrinology , pregnancy , arginine , biochemistry , chemistry , genetics , physics , amino acid , optics , biology
Patients with preeclampsia have higher circulating asymmetric dimethylarginine (ADMA). However, whether circulating ADMA is elevated before the diagnosis of preeclampsia has not been determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom